tiprankstipranks
Trending News
More News >
StemCell Institute (JP:7096)
:7096
Japanese Market
Advertisement

StemCell Institute (7096) Price & Analysis

Compare
0 Followers

7096 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.05%99.95%
Insiders
0.05%
Mutual Funds
― Other Institutional Investors
99.95% Public Companies and
Individual Investors

7096 FAQ

What was StemCell Institute’s price range in the past 12 months?
StemCell Institute lowest stock price was ¥911.00 and its highest was ¥1923.00 in the past 12 months.
    What is StemCell Institute’s market cap?
    StemCell Institute’s market cap is ¥11.33B.
      When is StemCell Institute’s upcoming earnings report date?
      StemCell Institute’s upcoming earnings report date is Aug 07, 2025 which is in 20 days.
        How were StemCell Institute’s earnings last quarter?
        Currently, no data Available
        Is StemCell Institute overvalued?
        According to Wall Street analysts StemCell Institute’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does StemCell Institute pay dividends?
          StemCell Institute pays a Notavailable dividend of ¥25 which represents an annual dividend yield of N/A. See more information on StemCell Institute dividends here
            What is StemCell Institute’s EPS estimate?
            StemCell Institute’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does StemCell Institute have?
            StemCell Institute has 10,246,600 shares outstanding.
              What happened to StemCell Institute’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of StemCell Institute?
              Currently, no hedge funds are holding shares in JP:7096

              Company Description

              StemCell Institute

              StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
              Similar Stocks
              Company
              Price & Change
              Follow
              StemRIM Inc.
              CellSource Co., Ltd.
              ReproCELL Inc.
              Japan Tissue Engineering Co., Ltd.
              CellSeed Inc.
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis